JP2023520400A5 - - Google Patents

Info

Publication number
JP2023520400A5
JP2023520400A5 JP2022559587A JP2022559587A JP2023520400A5 JP 2023520400 A5 JP2023520400 A5 JP 2023520400A5 JP 2022559587 A JP2022559587 A JP 2022559587A JP 2022559587 A JP2022559587 A JP 2022559587A JP 2023520400 A5 JP2023520400 A5 JP 2023520400A5
Authority
JP
Japan
Prior art keywords
alkyl
cyano
compound
tautomer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022559587A
Other languages
English (en)
Japanese (ja)
Other versions
JP7873172B2 (ja
JP2023520400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025614 external-priority patent/WO2021203023A1/en
Publication of JP2023520400A publication Critical patent/JP2023520400A/ja
Publication of JP2023520400A5 publication Critical patent/JP2023520400A5/ja
Application granted granted Critical
Publication of JP7873172B2 publication Critical patent/JP7873172B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022559587A 2020-04-03 2021-04-02 アルファ-1-アンチトリプシン欠損症(aatd)を治療するためのアルファ-1-アンチトリプシンモジュレーターとしてのインドール誘導体 Active JP7873172B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063004717P 2020-04-03 2020-04-03
US63/004,717 2020-04-03
PCT/US2021/025614 WO2021203023A1 (en) 2020-04-03 2021-04-02 Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)

Publications (3)

Publication Number Publication Date
JP2023520400A JP2023520400A (ja) 2023-05-17
JP2023520400A5 true JP2023520400A5 (cg-RX-API-DMAC10.html) 2024-04-10
JP7873172B2 JP7873172B2 (ja) 2026-06-11

Family

ID=75919370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022559587A Active JP7873172B2 (ja) 2020-04-03 2021-04-02 アルファ-1-アンチトリプシン欠損症(aatd)を治療するためのアルファ-1-アンチトリプシンモジュレーターとしてのインドール誘導体

Country Status (13)

Country Link
US (1) US20230159502A1 (cg-RX-API-DMAC10.html)
EP (1) EP4132908A1 (cg-RX-API-DMAC10.html)
JP (1) JP7873172B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220165260A (cg-RX-API-DMAC10.html)
CN (1) CN115916748B (cg-RX-API-DMAC10.html)
AR (1) AR121745A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021246526A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022019792A2 (cg-RX-API-DMAC10.html)
CA (1) CA3177531A1 (cg-RX-API-DMAC10.html)
IL (1) IL296920A (cg-RX-API-DMAC10.html)
MX (1) MX2022011829A (cg-RX-API-DMAC10.html)
TW (1) TWI908788B (cg-RX-API-DMAC10.html)
WO (1) WO2021203023A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20210060A1 (ar) 2018-10-05 2023-01-30 Vertex Pharma معدلات لمضاد تريبسين ألفا-1
US11884672B2 (en) 2019-05-14 2024-01-30 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
CN115697969B (zh) 2020-04-03 2026-08-11 弗特克斯药品有限公司 α-1抗胰蛋白酶调节剂
AU2021247285A1 (en) 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
JP7732999B2 (ja) * 2020-04-03 2025-09-02 バーテックス ファーマシューティカルズ インコーポレイテッド アルファ1-アンチトリプシンのモジュレーター
EP4188931A2 (en) 2020-07-27 2023-06-07 Vertex Pharmaceuticals Incorporated Processes for preparing modulators of alpha-1 antitrypsin
WO2022104353A1 (en) 2020-11-12 2022-05-19 Vertex Pharmaceuticals Incorporated Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat
CN120826396A (zh) * 2023-03-06 2025-10-21 英矽智能科技(上海)有限公司 Cdk8/19双重抑制剂及其使用方法
EP4687883A2 (en) * 2023-04-05 2026-02-11 Caraway Therapeutics, Inc. Modulators of trpml, their compositions and methods of use
WO2026136445A1 (en) 2024-12-17 2026-06-25 Sub21, Inc. A1at modulators

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639780A (en) * 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
IL154981A0 (en) * 2000-10-10 2003-10-31 Smithkline Beecham Corp Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
US6706423B2 (en) 2001-12-27 2004-03-16 Lightronik Technology Inc. Organic EL device
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US20070203209A1 (en) * 2005-08-18 2007-08-30 Wilmin Bartolini Useful indole compounds
AU2007234408B2 (en) * 2006-04-04 2011-05-19 Fibrogen, Inc. Pyrrolo- and thiazolo-pyridine compounds as HIF modulators
WO2008019357A2 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
GB0803017D0 (en) 2008-02-19 2008-03-26 Glaxo Group Ltd Compounds
RS54165B1 (sr) * 2008-04-16 2015-12-31 Karo Bio Ab Novi ligandi za estrogenski receptor
JPWO2012063753A1 (ja) 2010-11-08 2014-05-12 日本電気株式会社 インドール系化合物、並びにこれを用いた光電変換用色素、半導体電極、光電変換素子および光電気化学電池
US9012773B2 (en) * 2011-02-14 2015-04-21 Nec Corporation Thiazole-based compound and uses thereof
CA3103920C (en) * 2018-06-22 2025-09-16 Ucl Business Ltd COMPOUNDS FOR TREATING DISEASES MEDIATED BY ALPHA-1 ANTITRYPSIN
TWI748194B (zh) * 2018-06-28 2021-12-01 德商菲尼克斯 Fxr有限責任公司 含有雙環核心部分之新穎lxr調節劑
WO2021203007A1 (en) 2020-04-03 2021-10-07 Vertex Pharmaceuticals Incorporated Substituted 5-hydroxyindole compounds as modulators of alpha-1 antitrypsin

Similar Documents

Publication Publication Date Title
JP2021513967A5 (cg-RX-API-DMAC10.html)
JP2024504932A5 (cg-RX-API-DMAC10.html)
JP2022544714A5 (cg-RX-API-DMAC10.html)
JP2018535963A5 (cg-RX-API-DMAC10.html)
JP2019094345A5 (cg-RX-API-DMAC10.html)
JP2022545359A5 (cg-RX-API-DMAC10.html)
JP2021535174A5 (cg-RX-API-DMAC10.html)
JP2018536648A5 (cg-RX-API-DMAC10.html)
JP2006515858A5 (cg-RX-API-DMAC10.html)
RU2003105805A (ru) Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1
JP2023520207A5 (cg-RX-API-DMAC10.html)
RU2012122805A (ru) Производные ациламино-замещенной циклической карбоновой кислоты и их применение в качестве фармацевтических препаратов
JP2011509309A5 (cg-RX-API-DMAC10.html)
JP2009532486A5 (cg-RX-API-DMAC10.html)
IE902721A1 (en) "Intraocular pressure reducing 11-acyl prostaglandins"
RU97118591A (ru) Производные ацетамида, способ его получения и содержащие его фармацевтические композиции
JP2012530703A5 (cg-RX-API-DMAC10.html)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2024544060A5 (cg-RX-API-DMAC10.html)
JP2020534264A5 (cg-RX-API-DMAC10.html)
JP2022539126A (ja) ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用
JP2006513221A5 (cg-RX-API-DMAC10.html)
JP2025509404A5 (cg-RX-API-DMAC10.html)
JP2024517769A5 (cg-RX-API-DMAC10.html)
AU8629598A (en) Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them